These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32920821)

  • 41. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doubly robust estimation and causal inference for recurrent event data.
    Su CL; Steele R; Shrier I
    Stat Med; 2020 Jul; 39(17):2324-2338. PubMed ID: 32346897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Doubly Robust Nonparametric Multiple Imputation for Ignorable Missing Data.
    Long Q; Hsu CH; Li Y
    Stat Sin; 2012; 22():149-172. PubMed ID: 22347786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Causal mediation of semicompeting risks.
    Huang YT
    Biometrics; 2021 Dec; 77(4):1143-1154. PubMed ID: 34195991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjustment for Baseline Covariates to Increase Efficiency in RCTs with Binary Endpoint: A Comparison of Bayesian and Frequentist Approaches.
    Berchialla P; Sciannameo V; Urru S; Lanera C; Azzolina D; Gregori D; Baldi I
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alternative robust estimator of average treatment effect in causal inference.
    Liu J; Ma Y; Wang L
    Biometrics; 2018 Sep; 74(3):910-923. PubMed ID: 29441521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
    Taylor JM; Conlon AS; Elliott MR
    Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Data-Adaptive Bias-Reduced Doubly Robust Estimation.
    Vermeulen K; Vansteelandt S
    Int J Biostat; 2016 May; 12(1):253-82. PubMed ID: 27227724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Counting process-based dimension reduction methods for censored outcomes.
    Sun Q; Zhu R; Wang T; Zeng D
    Biometrika; 2019 Mar; 106(1):181-196. PubMed ID: 30799878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarker evaluation under imperfect nested case-control design.
    Wang X; Zheng Y; Jensen MK; He Z; Cai T
    Stat Med; 2021 Aug; 40(18):4035-4052. PubMed ID: 33915597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-dependent ROC curve estimation for interval-censored data.
    Beyene KM; El Ghouch A
    Biom J; 2022 Aug; 64(6):1056-1074. PubMed ID: 35523738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker.
    Wang X; Parast L; Tian LU; Cai T
    Biometrika; 2020 Mar; 107(1):107-122. PubMed ID: 32587413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints.
    Van der Elst W; Molenberghs G; Alonso A
    Stat Med; 2016 Apr; 35(8):1281-98. PubMed ID: 26612787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiply robust estimation of causal quantile treatment effects.
    Xie Y; Cotton C; Zhu Y
    Stat Med; 2020 Dec; 39(28):4238-4251. PubMed ID: 32857876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the information theory approach to evaluating time-to-event surrogate and true endpoints in a meta-analytic setting.
    Dimier N; Todd S
    Pharm Stat; 2021 Mar; 20(2):335-347. PubMed ID: 33145928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints.
    Gabriel EE; Sachs MC; Gilbert PB
    Stat Med; 2015 Feb; 34(3):381-95. PubMed ID: 25352131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjustment for missingness using auxiliary information in semiparametric regression.
    Zeng D; Chen Q
    Biometrics; 2010 Mar; 66(1):115-22. PubMed ID: 19432773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of outcome model misspecification on regression and doubly-robust inverse probability weighting to estimate causal effect.
    Lefebvre G; Gustafson P
    Int J Biostat; 2010; 6(2):Article 15. PubMed ID: 21969999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.